Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-14,594
Closed -$754K 1121
2020
Q1
$754K Buy
14,594
+8,470
+138% +$407K 0.02% 624
2019
Q4
$418K Buy
6,124
+896
+17% +$56.2K 0.01% 857
2019
Q3
$250K Buy
+5,228
New +$273K ﹤0.01% 957
2018
Q1
Sell
-7,248
Closed -$863K 1005
2017
Q4
$863K Buy
+7,248
New +$798K 0.01% 618
2016
Q2
Sell
-17,974
Closed -$808K 1013
2016
Q1
$808K Sell
17,974
-2,500
-12% -$89K 0.01% 685
2015
Q4
$821K Buy
+20,474
New +$866K 0.01% 629

Other funds holding INGN

Joel Greenblatt's INGN Position: Q2 2020 in Review

Joel Greenblatt sold out of Inogen (INGN) in Q2 2020, closing a stake of 14,594 shares — an estimated $754K sold.

Joel Greenblatt first reported a position in INGN in Q4 2015 and held it in 6 quarters. The position peaked at $863K in Q4 2017. 165 funds tracked by Wall St. Rank hold INGN as of Q2 2020.

  • Joel Greenblatt reported no remaining Inogen position as of Q2 2020 after selling out during the quarter.
  • Joel Greenblatt sold 14,594 Inogen shares in Q2 2020, an estimated $754K.
  • Joel Greenblatt first reported a position in Inogen in Q4 2015 and held it in 6 quarters.
  • Joel Greenblatt's Inogen position peaked at $863K in Q4 2017.
  • 165 funds tracked by Wall St. Rank held Inogen as of Q2 2020.

Based on Gotham Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.